Showing results (651-660 of 1,837) with videos related to

Sort By:
Pageof 184
ESMO Open|December 1, 2020
Uveal melanoma-associated cancers revisitedAhmad Samir Alfaar, Anas Saad, Shiema Elzouki, et al.
ESMO Open|January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near futureP Hofman, M Ilié, E Chamorey, et al.
ESMO Open|January 5, 2021
Molecular profiling of Asian patients with advanced melanoma receiving check-point inhibitor treatmentS Byeon, H J Cho, K-T Jang, et al.
ESMO Open|June 12, 2021
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgeryA Moreira, A Poulet, J Masliah-Planchon, et al.
ESMO Open|May 27, 2021
Strategies to tackle RAS-mutated metastatic colorectal cancerG Patelli, F Tosi, A Amatu, et al.
ESMO Open|October 30, 2020
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancerAnnalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, et al.
ESMO Open|October 28, 2020
Late decisions about treatment limitation in patients with cancer: empirical analysis of end-of-life practices in a haematology and oncology unit at a German university hospitalKatja Mehlis, Elena Bierwirth, Katsiaryna Laryionava, et al.
ESMO Open|July 29, 2021
Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)A Uutela, A Ovissi, A Hakkarainen, et al.
ESMO Open|July 5, 2022
Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of lifeE Van Cutsem, K Kato, J Ajani, et al.
ESMO Open|December 9, 2022
Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutationsH-Y Wang, S-G Wu, Y-T Lin, et al.
Pageof 184